Regeneron Pharmaceuticals Inc. (REGN)

Market is closed

Insider Trading: Sales

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Schleifer Officer, Director	$401.45	10,381	$4,167,452.45	137,766	2014-10-28	Filing
Schleifer Officer, Director	$400.52	12,322	$4,935,207.44	148,147	2014-10-28	Filing
Goldberg Officer	$404.18	1,035	$418,326.30	63,102	2014-10-24	Filing
Goldberg Officer	$403.50	2,454	$990,189.00	64,137	2014-10-24	Filing
Goldberg Officer	$402.54	2,500	$1,006,350.00	66,591	2014-10-24	Filing
Goldberg Officer	$401.51	5,293	$2,125,192.43	69,091	2014-10-24	Filing
Goldberg Officer	$400.51	7,531	$3,016,240.81	74,384	2014-10-24	Filing
Goldberg Officer	$399.37	3,200	$1,277,984.00	81,915	2014-10-24	Filing
Goldberg Officer	$398.58	2,100	$837,018.00	85,115	2014-10-24	Filing
Goldberg Officer	$397.65	1,700	$676,005.00	87,215	2014-10-24	Filing
Goldberg Officer	$396.80	775	$307,520.00	88,915	2014-10-24	Filing
Goldberg Officer	$395.96	200	$79,192.00	89,690	2014-10-24	Filing
Brown Director	$399.00	5,000	$1,995,000.00	0	2014-10-24	Filing
Vagelos Officer, Director	$350.07	10,326	$3,614,822.82	92,947	2014-09-10	Filing
Vagelos Officer, Director	$351.00	2	$702.00	103,273	2014-09-08	Filing
Tessier-Lavigne Director	$352.20	3,000	$1,056,600.00	1,187	2014-08-27	Filing
Goldstein Director	$350.31	2,000	$700,620.00	4,000	2014-08-27	Filing
Aberman Officer	$350.00	3,611	$1,263,850.00	15,600	2014-08-19	Filing
Mccorkle Officer	$353.00	5,875	$2,073,875.00	3,000	2014-08-18	Filing
Brown Director	$349.20	3,000	$1,047,600.00	0	2014-08-15	Filing